Rigel Pharmaceuticals
RIGL
RIGL
112 hedge funds and large institutions have $176M invested in Rigel Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 106 → 112 (+6)
0.85% more ownership
Funds ownership: 6.09% → 6.94% (+0.85%)
Holders
112
Holding in Top 10
–
Calls
$1.39M
Puts
$77K
Top Buyers
| 1 | +$31.8M | |
| 2 | +$1.14M | |
| 3 | +$661K | |
| 4 |
Squarepoint
New York
|
+$469K |
| 5 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$438K |
Top Sellers
| 1 | -$7.77M | |
| 2 | -$3.39M | |
| 3 | -$1.92M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.13M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$993K |